Dr Tsapekos, Dr Strawbridge, Becci Strawbridge & Professor Young present a poster at #ISAD2033 Accounting for premorbid IQ increases the proportion of cognitively impaired BD patients. This can have implications for screening in cognition trials and delivering cognitive interventions

The closing slide from Yuri Milaneschi’s Yuri Milaneschi talk today: Immuno-Metabolic Depression: Bringing precision psychiatry from research to the clinics #ISAD2023

Here is Jawaher S. Alnassar presenting her poster on ‘The impact of early life stress on adulthood personality traits.’ Other authors included Mario Juruena Adam Perkins and Professor Allan. H Young

Anna Tröger (a KCL CfAD PhD student) presents her poster, a meta-analysis and meta-regression reporting that: Baseline depression severity does not moderate the effects of psychotherapy compared with pharmacotherapy for depression. #ISAD2023

The time to say bye has come, as the Closing Ceremony took place at #ISAD2023! But first, ISAD President Prof Tony Cleare gave the prizes 🏆 to the Award winners for their outstanding work. Long applauses followed for the awardees – huge congrats everyone! 👏👏👏 THREAD 👇

1) Dr Rebecca Strawbridge Becci Strawbridge – Early Career Award Winner 🏆 #ISAD2023

3) Dr Clare Dolman DOLMAN CLARE – Patient Advocate Award 🏆 #ISAD2023

A wonderful poster (take a closer look at the infographics!) of a systematic review from the KCL CfAD team The Effects of single dose and repeated dose of Ketamine on cognition in Treatment-Resistant Depression Fatema Alhayyas, Laith Alexander 🏳️‍🌈 and Mario Juruena #ISAD2023

Fantastic setting for a conference in Milan, and (if I do say so myself) a wonderful academic event! See you for ISAD2024 and 2025! ISAD

KCL CfAD CRiB2 researchers Michael Kalfas and Rosie presented preliminary findings regarding the discrepancy between subjective and objective reports of cognitive performance at #ISAD2023 The implications for cognitive remediation therapy were discussed